{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T03:43:53Z","timestamp":1765079033299},"reference-count":26,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,7,7]],"date-time":"2008-07-07T00:00:00Z","timestamp":1215388800000},"content-version":"vor","delay-in-days":2709,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2001,2,5]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Although the eradication of <jats:italic>Helicobacter pylori<\/jats:italic> infection benefits patients with gastric or duodenal ulcers, the value of eradicating the infection in the patients with functional dyspepsia (FD) remains controversial.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aims:<\/jats:title><jats:p>To determine whether eradicating <jats:italic>H.\u2003pylori<\/jats:italic> can prevent the subsequent development of ulcers or relieve the symptoms of functional dyspepsia patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>In a double\u2010blind, placebo\u2010controlled trial, 161 patients infected with <jats:italic>H.\u2003pylori<\/jats:italic> who had functional dyspepsia were randomly assigned to 7\u2003days of treatment with a lansoprazole\u2010based triple therapy or placebo and then followed for 1\u2003year. The main outcome measures were the development of peptic ulcers and the resolution of symptoms.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p> <jats:italic>H.\u2003pylori<\/jats:italic> was eradicated in 63 out of 81 patients (78%) in the treatment group and none of the 80 patients (0%) in the placebo group. During the follow\u2010up period, two patients in the treatment group and six patients in the placebo group developed peptic ulcers at repeat endoscopy (2.5% vs. 7.5%; 95% CI: \u201312 to 2). The reduction in ulcer rates was statistically significant in the \u2018ulcer\u2010like\u2019 sub\u2010group (0% vs. 16.7%; 95% CI: \u201332 to \u20132), but not in the \u2018dysmotility\u2010like\u2019 and \u2018unclassifiable\u2019 sub\u2010groups. Regarding symptom response, the resolution rates of symptoms were similar between the treatment and placebo groups (58.0% vs. 55.0%, 95% CI: \u201312 to 18). Additionally, no significant differences existed in the symptom responses between the treatment and control arms in each of the dyspepsia sub\u2010groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>Eradicating <jats:italic>H.\u2003pylori<\/jats:italic> can prevent the subsequent development of peptic ulcers in the patients with \u2018ulcer\u2010like\u2019 functional dyspepsia. However, this approach does not significantly reduce the symptoms of functional dyspepsia patients.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.2001.00903.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:43:42Z","timestamp":1047354222000},"page":"195-201","source":"Crossref","is-referenced-by-count":70,"title":["Eradication of <i>Helicobacter pylori<\/i> prevents ulcer development in patients with ulcer\u2010like functional dyspepsia"],"prefix":"10.1111","volume":"15","author":[{"given":"P.\u2010I.","family":"Hsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.\u2010H.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.\u2010H.","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.\u2010H.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.\u2010C.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.\u2010K.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.\u2010S.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.\u2010H.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.\u2010K.","family":"Ku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.\u2010J.","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.\u2010J.","family":"Chien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.\u2010N.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,7,7]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.31.9.989"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)90764-P"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.31.4.401"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529109109531"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1998.tb00540.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811053391907"},{"key":"e_1_2_6_8_2","first-page":"145","article-title":"Functional dyspepsia: a classification with guideline for diagnosis and management","volume":"4","author":"Talley NJ","year":"1991","journal-title":"Gastroenterol Int"},{"key":"e_1_2_6_9_2","first-page":"576","article-title":"Management of dyspepsia: report of a working party","author":"Colin\u2010Jones DG","year":"1988","journal-title":"Lancet"},{"key":"e_1_2_6_10_2","first-page":"159","article-title":"Identification of subgroups of functional gastrointestinal disorders","volume":"3","author":"Drossman DA","year":"1990","journal-title":"Gastroenterol Int"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.45.2008.ii37"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529409092463"},{"key":"e_1_2_6_13_2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0889-8553(21)00269-7","article-title":"The role of Helicobacter pylori in nonulcer dyspepsia","volume":"22","author":"Lambert JR","year":"1993","journal-title":"Gastroenterol Clin North Am"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529609094532"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199812243392601"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199812243392602"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.318.7187.833"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026603023032"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529709025095"},{"key":"e_1_2_6_20_2","first-page":"59","article-title":"A 5\u2010year follow\u2010up study of chronic gastritis patients","volume":"161","author":"Matysiak\u2010Budnik T","year":"1992","journal-title":"Ir J Med Sci"},{"key":"e_1_2_6_21_2","first-page":"A219","article-title":"Overlapping irritable bowel syndrome and delayed gastric emptying identify different subgroups among patients with functional dyspepsia","volume":"39","author":"Tosetti C","year":"1996","journal-title":"Gut"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199712000-00007"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.40.4.459"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6138.653"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)90004-I"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(94)90007-8"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.36.4.534"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2001.00903.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2001.00903.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2001.00903.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T01:33:40Z","timestamp":1697506420000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2001.00903.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,2,5]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,2,5]]}},"alternative-id":["10.1046\/j.1365-2036.2001.00903.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2001.00903.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,2,5]]}}}